Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05709860 · ClinicalTrials.gov registry record · NA
An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT05709860 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 200 participants.
The verdict
NCT05709860, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
This study is being conducted to investigate a strategy that may improve knowledge and uptake of pre-exposure prophylaxis for HIV prevention (PrEP) among cisgender women in primary care.
Interventions
- BEHAVIORAL EMC2 PrEP Educational Tool
- BEHAVIORAL Discrete Scheduling of a Dedicated PrEP Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-11-29 |
| Est. Completion | 2024-10-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05709860
The ClinicalTrials.gov registry entry for NCT05709860 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EMC2 PrEP Educational Tool is the first listed.
NCT05709860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05709860 about?
NCT05709860 is a clinical study titled "An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy". This study is being conducted to investigate a strategy that may improve knowledge and uptake of pre-exposure prophylaxis for HIV prevention (PrEP) among cisgender women in primary care.
What is the current status of trial NCT05709860?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2023-11-29. Estimated completion is 2024-10-29.
What interventions are being tested in trial NCT05709860?
The interventions under investigation include: EMC2 PrEP Educational Tool (BEHAVIORAL), Discrete Scheduling of a Dedicated PrEP Visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT05709860?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.